Lipoprotein(a) Is Associated With Increased Risk of Abdominal Aortic Aneurysm.

ABSTRACT: Lp(a) is a genetically determined lipoprotein targeted by emerging therapies. In a UK Biobank analysis (1,026 abdominal aortic aneurysm [AAA] cases, 469,989 controls), elevated Lp(a) was associated with increased risk of AAA, including at clinically relevant thresholds while controlling for traditional risk factors, including ApoB. Multivariable Mendelian randomization confirmed a causal relationship between lipoprotein(a) [Lp(a)] and AAA independent of apolipoprotein B. These findings support Lp(a) as a modifiable risk factor and potential therapeutic target for AAA, a condition with limited medical treatment options. AAA should be considered as an outcome in future clinical trials of Lp(a)-lowering therapies.

SUBMITTER: Sharma P 

PROVIDER: S-EPMC12809141 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature